Doxazosin Tablet
Product Images NDC 68382-784
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 68382-784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Doxazosin Tablets (A308818e E36c 4431 Bf51 274650c38cb0 02)
This text provides data from three studies that evaluated the effectiveness of Doxazosin in treating hypertension with BPH. The studies looked at the efficacy of different doses of Doxazosin compared to a placebo, using the AUA questionnaire and the Modified Boyarsky Questionnaire to score symptoms. The text shows changes in the endpoint and the mean values of the scores obtained in each study.*
Doxazosin Tablets, Usp (A308818e E36c 4431 Bf51 274650c38cb0 03)
Container Label 1 mg (100s count)
This is a description of a medication called Doxazosin, which is a type of antihypertensive medication used to treat high blood pressure and enlargement of the prostate gland. It is available in the form of tablets with a strength of 1 mg. The tablets are distributed by Zydus Pharmaceuticals and come in a bottle containing 100 tablets. The seal on the tablets are controlled by USP and require a temperature-controlled environment.*
Container Label 2 mg- 100s Count (A308818e E36c 4431 Bf51 274650c38cb0 05)
Container Label 4 mg (100s count)
Container Label (8 mg)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.